Literature DB >> 7614912

Histamine in cerebrospinal fluid of children with febrile convulsions.

T Kiviranta1, L Tuomisto, E M Airaksinen.   

Abstract

Febrile convulsions (FC) are frequent acute neurologic disturbances of childhood. The cellular and neurochemical mechanisms causing FC are unclear. Among other mechanisms, the CNS histamine (HA) has been suggested to participate in seizure control and thermoregulation. We evaluated the possible role of HA in regulation of FC by measuring HA and tele-methylhistamine (t-MH) concentrations in the cerebrospinal fluid (CSF) of children with FC. The study group consisted of 35 children treated for acute FC in the hospital. The control groups consisted of (a) feverish children without seizures (n = 23), (b) convulsive children without fever (n = 7), and (c) children with neither fever nor convulsions (n = 21). HA was assayed by high-performance liquid chromatography (HPLC) with fluorescence detection, and t-MH was measured by gas chromatography-mass spectrometry. CSF HA concentration in the group of febrile children without seizures was significantly higher (0.69 +/- 0.16 pmol/ml, mean +/- SE) than in children with FC (0.36 +/- 0.07 pmol/ml, p < 0.05, analysis of variance, ANOVA). HA concentration was 0.37 +/- 0.18 pmol/ml in the group of nonfebrile convulsive children and 0.36 +/- 0.08 pmol/ml in the nonfebrile nonconvulsive group. No statistical differences in t-MH were detected between groups. The increased susceptibility to seizures during fever may be connected to the lack of increase in CSF HA in the FC group. The data support the hypothesis that the central histaminergic neuron system may be involved in inhibition of seizures associated with febrile illnesses in childhood.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614912     DOI: 10.1111/j.1528-1157.1995.tb00996.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system.

Authors:  Tiina-Kaisa Kukko-Lukjanov; Sanna Soini; Tomi Taira; Kimmo A Michelsen; Pertti Panula; Irma E Holopainen
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.

Authors:  David B Rye
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

3.  Quantification of histamine in various fish samples using square wave stripping voltammetric method.

Authors:  Ummihan Taskoparan Yilmaz; Derya Inan
Journal:  J Food Sci Technol       Date:  2015-02-10       Impact factor: 2.701

4.  Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.

Authors:  Yves Dauvilliers; Nathalie Delallée; Isabelle Jaussent; Sabine Scholz; Sophie Bayard; Mickael Croyal; Jean-Charles Schwartz; Philippe Robert
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

Review 5.  Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Authors:  M Bhowmik; R Khanam; D Vohora
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

6.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

7.  Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.

Authors:  Seiji Nishino; Eiko Sakurai; Sona Nevsimalova; Yasushi Yoshida; Takehiko Watanabe; Kazuhiko Yanai; Emmanuel Mignot
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  The relationship between drug treatment and the clinical characteristics of febrile seizures.

Authors:  Wakako Haruyama; Tatsuo Fuchigami; Yukio Noguchi; Ayumi Endo; Koji Hashimoto; Yasuji Inamo; Yukihiko Fujita; Shigeru Takahashi; Hideo Mugishima
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

Review 9.  Use and Future Prospects of in Vivo Microdialysis for Epilepsy Studies.

Authors:  Alexander G Zestos; Hiram Luna-Munguia; William C Stacey; Robert T Kennedy
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

10.  Impaired histaminergic neurotransmission in children with narcolepsy type 1.

Authors:  Patricia Franco; Yves Dauvilliers; Clara Odilia Inocente; Aurore Guyon; Carine Villanueva; Veronique Raverot; Sabine Plancoulaine; Jian-Sheng Lin
Journal:  CNS Neurosci Ther       Date:  2018-09-17       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.